Access cutting-edge conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kansas City location
Preparing your pre-screening questions…
Access conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound treatment provided free
Check if you qualify for this conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound clinical trial in Kansas City, MO
No-Cost Study Care
Local to Kansas City
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Hyperfine Research, Inc. has taken advantage of technological advances and developed an MRI device that is not only portable, but also uses a very-low magnetic field strength, \[less than 0.2 Tesla or approximately 10 times less\] than the field strength of conventional devices. This critical difference allows HRI to address MRI's core challenges by, first, operating at very low magnetic field strengths, eliminating the need for special rooms or shielding. Second, there are minimal safety concerns regarding ferrous metals near the system, as the field strength is too low to attract metal objects. The removal of metal, including items such as jewelry, belts, etc. from clothing and person, prior to being scanned, is unnecessary. Third, the design constraints faced by conventional MRI systems are lifted at low magnetic field and an open device has been designed to minimize anxiety that may come with claustrophobic patients. All of this is possible while still providing image quality that is clinically relevant to a wide variety of fields, including radiology, neurology, pediatrics, emergency medicine, and others.
Sponsor: Children's Mercy Hospital Kansas City
Yes, this clinical trial (NCT04629469) has an active research site in Kansas City, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound treatment options in Kansas City, MO, this clinical trial (NCT04629469) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all conditions requiring a brain magnetic resonance imaging, head computerized tomography, or head ultrasound clinical trials near you to find additional studies recruiting in your area.
See all neuroendocrine tumors clinical trials recruiting in Kansas City — not just this study.
Browse Neuroendocrine Tumors Trials in Kansas City →